| Title |
What is the mechanism whereby cannabis use increases risk of psychosis?
|
|---|---|
| Published in |
Neurotoxicity Research, June 2008
|
| DOI | 10.1007/bf03033802 |
| Pubmed ID | |
| Authors |
Sonija Luzi, Paul D. Morrison, John Powell, Marta Di Forti, Robin M. Murray |
| Abstract |
Cannabis use has increased greatly over the last three decades. The various types of cannabis differ in their concentration of the main psychoactive component, Delta-9-tetrahydrocannabinol (THC), and the other major ingredient, cannabidiol (CBD). Plant engineering has maximized levels of THC, thus increasing the potency of street cannabis. It is well known that cannabis intoxication can cause brief psychotic symptoms like paranoia, whilst recent evidence demonstrates that heavy use of cannabis increases the risk of chronic psychoses like schizophrenia; genetic vulnerability seems to predispose some people to a higher risk. This paper starts to consider the neurochemical mechanisms whereby cannabis use increases the risk of psychosis. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 43% |
| Austria | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Brazil | 2 | 1% |
| United Kingdom | 2 | 1% |
| Hungary | 1 | <1% |
| Italy | 1 | <1% |
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 127 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 33 | 24% |
| Student > Ph. D. Student | 15 | 11% |
| Student > Master | 14 | 10% |
| Researcher | 13 | 9% |
| Professor | 10 | 7% |
| Other | 33 | 24% |
| Unknown | 20 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 40 | 29% |
| Agricultural and Biological Sciences | 21 | 15% |
| Psychology | 20 | 14% |
| Neuroscience | 10 | 7% |
| Biochemistry, Genetics and Molecular Biology | 5 | 4% |
| Other | 12 | 9% |
| Unknown | 30 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2021.
All research outputs
#1,988,250
of 24,965,047 outputs
Outputs from Neurotoxicity Research
#38
of 916 outputs
Outputs of similar age
#5,180
of 92,974 outputs
Outputs of similar age from Neurotoxicity Research
#3
of 6 outputs
Altmetric has tracked 24,965,047 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 916 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 92,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.